does tirzepatide cause anemia vs. Semaglutide: Which Is Better For You ? Understanding Tirzepatide Side Effects, Risks

What should I avoid at all costs

To view or add a comment, sign in Findings: Patients initiating semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure or all-cause mortality compared with sitagliptin (a glucose-lowering drug with no effect on heart failure end points)

The newlyapproved innovative drug will be suitable for obese or overweight patients withan initial BMI of 30kg/m2 or greater or between 27kg/m2 and 30kg/m2 with atleast one weight-related comorbiditis

Dysregulation in these pathways could result in heightened pain sensitivity

GLP-1 is a hormone found naturally in our bodies that is insufficient in people who have type 2 diabetes

We encourage our patients to engage in a comprehensive discussion with our healthcare team about their medical history and existing medications to see if Mounjaro is the suitable addition to their diabetes management regimen